Gilead Sciences Inc. (GILD) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Gilead Sciences Inc.

    NASDAQ: GILD · Real-Time Price · USD
    112.69
    2.13 (1.93%)
    At close: Oct 03, 2025, 3:59 PM
    112.85
    0.14%
    After-hours: Oct 03, 2025, 07:55 PM EDT

    Gilead Sciences Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 480M 5.67B 4.59B 6.2B
    Depreciation & Amortization
    		 2.77B 2.69B 2.1B 2.05B
    Stock-Based Compensation
    		 835M 766M 644M 635M
    Other Working Capital
    		 -883M -1.27B -1.27B 283M
    Other Non-Cash Items
    		 9.47B 2.15B 5.05B 2.13B
    Deferred Income Tax
    		 -1.84B -962M -1.55B -116M
    Change in Working Capital
    		 -880M -2.3B -1.76B 489M
    Operating Cash Flow
    		 10.83B 8.01B 9.07B 11.38B
    Capital Expenditures
    		 -523M -585M -728M -579M
    Cash Acquisitions
    		 -4.84B -1.15B -1.8B -1.58B
    Purchase of Investments
    		 -736M -2.37B -1.94B -3.9B
    Sales Maturities Of Investments
    		 2.59B 1.84B 2B 2.91B
    Other Investing Acitivies
    		 58M n/a -1M 19M
    Investing Cash Flow
    		 -3.45B -2.27B -2.47B -3.13B
    Debt Repayment
    		 1.49B -270M -1.5B -4.75B
    Common Stock Repurchased
    		 -1.15B -1B -1.4B -546M
    Dividend Paid
    		 -3.92B -3.81B -3.71B -3.6B
    Other Financial Acitivies
    		 -281M -278M -173M -145M
    Financial Cash Flow
    		 -3.43B -5.13B -6.47B -8.88B
    Net Cash Flow
    		 3.91B 673M 74M -659M
    Free Cash Flow
    		 10.3B 7.42B 8.34B 10.8B

    Add to Watchlist